Poznaj tematy Late Breaking Trials – TCT 2011

763 0
Udostępnij
763 0

W nadchodzącym miesiącu  (7-11 listopada, 2011) w San Francisco odbędzie się kongres Transcatheter Therapeutics (TCT, www.tctconference.com) należący do największy spotkań poświęconych przezskórnym technikom leczenia chorób układu sercowo-naczyniowego. W tym roku organizatorzy przygotowali 7 sesji badań klinicznych, w trakcie których zostaną przedstawiony wyniki 22 badań klinicznych. Poniżej tematy tegorocznych sesji.

Środa, 9 listopada 2011

9:00 – 10:00

Moderatorzy: Ajay J. Kirtane, MD, SM

9:00 ADAPT-DESA Large-Scale, Prospective, Multicenter Registry Examining the Relationship of Platelet Responsiveness and Stent Thrombosis After DES ImplantationGregg W. Stone, MD
9:10 PARISA Large-Scale, Prospective, Multicenter Registry Studying the Patterns of and Reasons for Non-Adherence to Antiplatelet Agents in Stented PatientsRoxana Mehran, MD
9:20 DESERTA Large-Scale, Multicenter, Case-Controlled Study Examining the Predictors of Stent ThrombosisRon Waksman, MD
9:30 RAPID GENEA Prospective, Randomized Trial of Prasugrel vs. Clopidogrel in CYP2C19*2 Carriers Identified by Rapid Point-of-Care GenotypingDerek So, MD
9:40 TRIGGER-PCIA Prospective, Randomized Trial of Prasugrel vs. Clopidogrel in Clopidogrel-Hyporesponsive Patients with Stable Ischemic Heart Disease Undergoing Percutaneous Coronary InterventionDietmar Trenk, PhD
9:50 BRIDGEA Prospective, Double-Blind, Multicenter, Randomized Placebo-Controlled Trial of Intravenous Cangrelor in Patients Awaiting SurgeryDominick J. Angiolillo, MD, PhD

Czwartek, 10 listopada 2011

9:00 – 10:10

Moderatorzy:   Alexandra J. Lansky, MD

9:00 PARTNER Cohort B Two-YearA Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement vs. Standard Therapy in Patients with Inoperable Aortic StenosisRaj Makkar, MD
9:10 PARTNER Cohort A CECost-Effectiveness Analysis from a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement vs. Surgical Aortic Valve Replacement in High-Surgical-Risk Patients with Aortic StenosisMatthew R. Reynolds, MD
9:20 STACCATOA Prospective, Randomized Trial of Transapical Transcatheter Aortic Valve Replacement vs. Surgical Aortic Valve Replacement in Low-Surgical-Risk Elderly Patients with Aortic StenosisLeif Thuesen, MD
9:30 RIFLE STEACSA Prospective, Randomized Trial of Radial vs. Femoral Vascular Access in Patients with ST-Segment Elevation Myocardial InfarctionEnrico Romagnoli, MD, PhD
9:40 MUSTELAA Prospective, Randomized Trial of Thrombectomy vs. No Thrombectomy in Patients with ST-Segment Elevation Myocardial Infarction and Thrombus-Rich LesionsAnna Sonia Petronio, MD
9:50 DEB-AMIA Prospective, Randomized Trial of Paclitaxel-Coated Balloons plus Bare Metal Stents vs Paclitaxel-Eluting Stents vs. Bare Metal Stents Alone in Patients with ST-Segment Elevation Myocardial InfarctionPieter R. Stella, MD, PhD
10:00 PARTNER Cohort A QOLQuality-of-Life Analysis from a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement vs. Surgical Aortic Valve Replacement in High-Surgical-Risk Patients with Aortic StenosisDavid J. Cohen, MD

Piątek, 11 listopada 2011

9:00– 10:30

Moderator: Roxana Mehran, MD

9:00 EVOLVEA Prospective, Randomized Trial of Two Dose Formulations of a Bioabsorbable Polymer-Based Everolimus-Eluting Stent vs. a Durable Polymer-Based Everolimus-Eluting StentIan T. Meredith, MBBS, PhD
9:10 NEXTA Prospective, Randomized Trial Comparing Cre8, a Polymer-Free Stent Eluting Sirolimus, toa Paclitaxel-Eluting Stent

Didier Carrie, MD, PhD

9:20 PEPCAD-DESA Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. Uncoated Balloon Angioplasty in Patients with Restenosis of Drug-Eluting StentsHarald Rittger, MD
9:30 TWENTEA Prospective, Randomized Trial of Zotarolimus-Eluting Stents and Everolimus-Eluting Stents in Patients with Coronary Artery DiseaseClemens von Birgelen, MD, PhD
9:40 ROTAXUSA Prospective, Randomized Trial of High-Speed Rotational Atherectomy Prior to Paclitaxel-Eluting Stent Implantation in Complex Calcified Coronary Artery LesionsGert Richardt, MD, PhD
9:50 ADVISEValidation of a Vasodilator Independent Measure of Coronary Fractional Flow ReserveJustin Davies, MBBS, MRCP, PhD
10:00 COBRAA Prospective, Randomized Trial of Cryoplasty vs. Conventional Balloon Postdilatation of Nitinol Stents in the Superficial Femoral Artery of Patients with Diabetes MellitusSubhash Banerjee, MD
10:10 PROFIA Prospective, Randomized Trial of Proximal Balloon Occlusion vs. Distal Filter Embolic Protection in Patients Undergoing Carotid StentingJoachim Schofer, MD
10:20 REMEDEEA Prospective, Randomized Trial of a Combination Bioabsorbable Polymer-Based Anti-CD34 Antibody Sirolimus-Eluting Stent vs. a Durable Polymer-Based Paclitaxel-Eluting StentMichael Haude, MD
Udostępnij
Artykuł w kategoriach

Dołącz do dyskusji


Treść na stronie do której próbujesz uzyskać dostęp jest przeznaczona tylko dla lekarzy. Proszę o odpowiedź na pytanie: Czy jesteś lekarzem?

Oświadczam, że jestem lekarzem

Powered by WordPress Popup